| Literature DB >> 30599003 |
Fernanda S Marinho1, Camila B M Moram1, Priscila C Rodrigues1, Nathalie C Leite2, Gil F Salles2, Claudia R L Cardoso2.
Abstract
OBJECTIVES: To investigate treatment adherence in patients with type 2 diabetes and to evaluate its associated factors.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30599003 PMCID: PMC6288575 DOI: 10.1155/2018/8970196
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Results of the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire in 476 type 2 diabetic patients.
| Self-care activities | Number of days∗ |
|---|---|
| General diet questions | |
| Follow a healthful eating plan in the last week | 0 (0–6) |
| Follow an eating plan (on average per week, over the past month) | 0 (0–6) |
| Specific diet questions | |
| Eat five or more servings of fruits and vegetables in the last week | 0 (0–7) |
| Eat high-fat foods in the last week | 4 (2–7) |
| Eat sweets in the last week | 1 (0–2) |
| Exercise | |
| Participate in at least 30 minutes of physical activity, in the last week | 7 (3–7) |
| Participate in a specific exercise session in the last week | 0 (0–2) |
| Blood sugar testing (patients using insulin = 311) | |
| Test blood sugar in the last week | 2 (0–7) |
| Test blood sugar according to the number of times recommended by your health care provider in the last week | 5.5 (0–7) |
| Foot care | |
| Check feet in the last week | 7 (1–7) |
| Inspect the inside of shoes in the last week | 7 (0–7) |
| Dry between toes after washing, in the last week | 7 (7–7) |
| Medications | |
| Take recommended diabetic medications in the last week | 7 (7–7) |
| Take recommended insulin injections in the last week | 7 (7–7) |
| Take recommended number of diabetes pills in the last week | 7 (7–7) |
| Smoking | |
| Patients who smoked during the past 7 days (%) | 6.1 |
| Number of cigarettes smoked in a day | 13 (5–15) |
| Never smokers (%) | 51.5 |
| Past smokers (%) | 42.4 |
∗Values are the median number of days and interquartile range, except for smoking status, which are proportions and median number of cigarettes (for current smokers).
Figure 1Summary of Diabetes Self-Care Activities and percentage of affirmative answers to SDSCA of 5 days or more, except for sweets and fat food that were considered affirmative answers to two days or less.
Characteristics of all patients and according to general adherence (5 or more days per week in all items of the SDSCA questionnaire, except in exercise).
| Characteristics | All patients | Adherent patients | Nonadherent patients |
|
|---|---|---|---|---|
| Age (years) | 65 (10.7) | 64 (11.7) | 65 (10.5) | 0.29 |
| Diabetes duration (years) | 8 (3–15) | 8 (3–15) | 8 (3–15) | 0.94 |
| Gender, female (%) | 63.9 | 63.6 | 64.9 | 0.82 |
| Schooling years, ≥8 years (%) | 25.5 | 24.9 | 27.5 | 0.59 |
| Social security situation (% of retirement) | 38 | 43.6 | 36.6 | 0.69 |
| Marital status (% of married) | 64.1 | 70.1 | 62.6 | 0.48 |
| Body mass index (kg/m2) | 29.8 (4.7) | 28.7 (4.1) | 30.1 (4.8) | 0.005 |
| Diabetes treatment (%) | ||||
| Metformin | 86.8 | 86.6 | 86.9 | 0.95 |
| Sulfonylureas | 20.8 | 21.5 | 20.6 | 0.86 |
| Insulin | 68.4 | 67.7 | 68.5 | 0.89 |
| Chronic diabetic complications (%) | ||||
| Retinopathy | 31.0 | 34.8 | 30.1 | 0.38 |
| Nephropathy | 28.2 | 28.0 | 28.2 | 0.96 |
| Peripheral neuropathy | 27.4 | 24.5 | 28.2 | 0.47 |
| Cerebrovascular disease | 6.5 | 7.4 | 6.3 | 0.68 |
| Coronary artery disease | 14.7 | 16.0 | 14.4 | 0.70 |
| Peripheral arterial disease | 13.5 | 12.6 | 17.0 | 0.26 |
| Arterial hypertension (%) | 85.3 | 81.9 | 86.1 | 0.30 |
| SBP (mmHg) | 139 (18) | 139 (20) | 138 (18) | 0.81 |
| DBP (mmHg) | 76 (11) | 75 (11) | 76 (11) | 0.34 |
| Dyslipidemia (%) | 87.6 | 85.1 | 88.2 | 0.41 |
| Laboratory variables | ||||
| HbA1c (%) (mmol/mol) | 7.9 (1.6) | 7.9 (1.6) | 7.9 (1.7) | 0.98 |
| 63 (15.6) | 63 (15.6) | 63 (15.7) | ||
| LDL cholesterol (mmol/L) | 2.46 (0.78) | 2.45 (0.69) | 2.46 (0.81) | 0.92 |
| HDL cholesterol (mmol/L) | 1.19 (0.36) | 1.27 (0.36) | 1.17 (0.35) | 0.007 |
| Triacylglycerol (mmol/L) | 1.46 (1.07–2.04) | 1.29 (0.97–1.73) | 1.50 (1.11–2.13) | 0.003 |
| Domains of quality of life (SF-36) | ||||
| Functional capacity | 49 (31.5) | 56 (32.3) | 47 (31.1) | 0.011 |
| Emotional | 58 (45.6) | 68 (43.3) | 55 (46.0) | 0.014 |
| Pain | 51 (30.3) | 56 (30.8) | 49 (30.1) | 0.041 |
| Occupational performance (COPM) | 4.6 (1.9) | 5.2 (2.0) | 4.4 (1.9) | 0.001 |
| Satisfaction in the performance of activities (COPM) | 4.3 (2.3) | 4.8 (2.5) | 4.2 (2.2) | 0.035 |
| Limitations/pain (%) | ||||
| In the upper limb | 52.3 | 37.2 | 56.0 | 0.001 |
| In the lower limb | 60.3 | 47.9 | 63.4 | 0.006 |
| In the spine | 54.8 | 54.3 | 55.0 | 0.90 |
Values are the proportions, means (standard deviations), or medians (interquartile range). Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; COPM, Canadian Occupational Performance Measure.
Results of multiple logistic regressions for variables associated with general adherence and, for specific items of diet, exercise and medication adherence of the SDSCA questionnaire.
| Dependent variable/independent covariates | OR | 95% CI |
|
|---|---|---|---|
| General adherence∗ | |||
| HDL cholesterol (10 mg/dL increase) | 1.25 | 1.06–1.47 | 0.008 |
| SF-36 emotional domain (each 10-point increase) | 1.07 | 1.01–1.12 | 0.021 |
| BMI (1 kg/m2 increase) | 0.94 | 0.89–0.99 | 0.021 |
| Age (1 year increase) | 0.98 | 0.96–0.998 | 0.033 |
| Presence of macrovascular complications (yes/no) | 1.62 | 0.96–2.37 | 0.073 |
| General adherence∗∗ | |||
| Pain/limitation in the upper limbs (yes/no) | 0.49 | 0.30–0.81 | 0.006 |
| HDL cholesterol (10 mg/dL increase) | 1.25 | 1.06–1.47 | 0.008 |
| COPM (each 1-point increase) | 1.18 | 1.04–1.35 | 0.012 |
| Age (1-year increase) | 0.97 | 0.95–0.99 | 0.014 |
| SF-36 emotional domain (each 10-point increase) | 1.07 | 1.01–1.12 | 0.021 |
| Presence of macrovascular complications (yes/no) | 1.88 | 1.09–3.23 | 0.022 |
| BMI (1 kg/m2 increase) | 0.96 | 0.91–1.01 | 0.098 |
| General diet∗ | |||
| HDL cholesterol (10 mg/dL increase) | 1.19 | 1.02–1.37 | 0.022 |
| SF-36 pain domain (each 10-point increase) | 1.08 | 1.01–1.16 | 0.033 |
| SF-36 emotional domain (each 10-point increase) | 1.04 | 0.99–1.09 | 0.076 |
| General diet∗∗ | |||
| COPM (each 1-point increase) | 1.22 | 1.09–1.36 | 0.001 |
| Pain/limitation in the upper limbs (yes/no) | 0.59 | 0.38–0.90 | 0.015 |
| HDL cholesterol (10 mg/dL increase) | 1.19 | 1.02–1.38 | 0.025 |
| Exercise∗ | |||
| SF-36 pain domain (each 10-point increase) | 1.13 | 1.04–1.21 | 0.002 |
| SF-36 emotional domain (each 10-point increase) | 1.09 | 1.03–1.15 | 0.003 |
| BMI (1 kg/m2 increase) | 0.94 | 0.89–0.99 | 0.011 |
| Presence of peripheral neuropathy (yes/no) | 0.55 | 0.31–0.95 | 0.032 |
| Exercise∗∗ | |||
| SF-36 emotional domain (each 10-point increase) | 1.08 | 1.02–1.14 | 0.009 |
| BMI (1 kg/m2 increase) | 0.94 | 0.90–0.99 | 0.029 |
| Presence of peripheral neuropathy (yes/no) | 0.55 | 0.31–0.95 | 0.032 |
| Pain/limitation in the spine (yes/no) | 0.61 | 0.39–0.98 | 0.039 |
| COPM (each 1-point increase) | 1.12 | 0.99–1.27 | 0.066 |
| Female gender | 1.53 | 0.95–2.45 | 0.082 |
| Medication† | |||
| HbA1c (1% increase) | 0.73 | 0.62–0.86 | <0.001 |
| BMI (1 kg/m2 increase) | 0.92 | 0.86–0.99 | 0.022 |
| Diabetes duration (1-year increase) | 1.04 | 0.99–1.09 | 0.059 |
∗The candidate variables to enter these models were BMI, diabetes duration, SF-36 pain, physical activity and emotional domains, presence of macrovascular and microvascular complications, blood pressure, glycated hemoglobin, and LDL and HDL cholesterol. ∗∗Pain or joint limitation on the spine and lower and upper limbs and COPM entered the model instead of SF-36 pain and physical domain items. †Both models were identical. Age and gender were forced into all models. Abbreviations: BMI, body mass index; COPM, Canadian Occupational Performance Measure.